Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 1854 questions Show Answers
To ask the Scottish Government how many fluoride varnish applications were delivered to children under the ChildSmile Nursery and School programme between March and October (a) 2019 and (b) 2020.
To ask the Scottish Government what assessment it has made of the potential impact of the COVID-19 pandemic on oral health inequalities among children.
To ask the Scottish Government how many hospital patient deaths from COVID-19 have been recorded in each month since March 2020, also broken down by how many of these people had at least one other underlying health condition.
To ask the Scottish Government what the uptake level has been for the COVID-19 testing that has been offered to staff working in specialist cancer services.
To ask the Scottish Government how it will ensure that there is sufficient workforce capacity to manage the backlog of cases in cancer diagnostic services.
To ask the Scottish Government what assessment it has made of how any reductions to NHS boards’ budgets for programmes or measures that aim to reduce the harms associated with drug use will impact on its ambition to eliminate hepatitis C by 2024.
To ask the Scottish Government how many dental packs were distributed to children as part of the ChildSmile Core programme between March and October (a) 2019 and (b) 2020.
To ask the Scottish Government what percentage of schools and nurseries that participated in the ChildSmile Core programme in March 2020 have now restored daily supervised toothbrushing.
To ask the Scottish Government how many home visits dental health support workers delivered in each month in 2020 as part of the ChildSmile Practice programme.
To ask the Scottish Government what assessment it has made of the impact of COVID-19 on access to (a) needle and syringe exchange programmes and (b) opioid substitution therapy.